We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$34.7B
Cap. Flow
% of AUM
-172.71%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$75M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$66.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$64.8M |
| 4 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$50.3M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.53B |
| 2 |
Microsoft
MSFT
|
+$1.91B |
| 3 |
Apple
AAPL
|
+$1.42B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Meta Platforms (Facebook)
META
|
+$836M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
AnaptysBio
ANAB
$1.66B
| $20.2K | ﹤0.01% |
816
-11,315
| -93% | -$263K |
|
1377
Cerence
CRNC
$389M
| $19.9K | ﹤0.01% |
7,241
-352,589
| -98% | -$2.51M |
|
1378
Scholar Rock
SRRK
$6.46B
| $19.9K | ﹤0.01% |
2,381
-10,206
| -81% | -$125K |
|
|
AUTL
1379
Autolus Therapeutics
AUTL
$591M
| $19.8K | ﹤0.01% |
+5,955
| New | +$25.7K |
|
1380
Arcturus Therapeutics
ARCT
$223M
| $19.7K | ﹤0.01% |
804
-14,269
| -95% | -$433K |
|
|
PETQ
1381
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $19.5K | ﹤0.01% |
881
-12,016
| -93% | -$231K |
|
|
SAGE
1382
DELISTED
Sage Therapeutics
SAGE
| $19.2K | ﹤0.01% |
1,797
-36,771
| -95% | -$471K |
|
1383
Pliant Therapeutics
PLRX
$66.9M
| $19.2K | ﹤0.01% |
+1,801
| New | +$23.2K |
|
1384
Prime Medicine
PRME
$575M
| $19.1K | ﹤0.01% |
+3,584
| New | +$21.7K |
|
1385
BILL Holdings
BILL
$5.11B
| $19K | ﹤0.01% |
362
-145,082
| -100% | -$8.21M |
|
1386
Travere Therapeutics
TVTX
$5.79B
| $18.8K | ﹤0.01% |
2,273
-47,905
| -95% | -$323K |
|
1387
Lexicon Pharmaceuticals
LXRX
$1.04B
| $18.8K | ﹤0.01% |
+10,792
| New | +$19.4K |
|
1388
Olema Pharmaceuticals
OLMA
$920M
| $18.7K | ﹤0.01% |
1,670
-8,869
| -84% | -$96.2K |
|
1389
IPG Photonics
IPGP
$3.57B
| $18.7K | ﹤0.01% |
224
-30,451
| -99% | -$2.63M |
|
1390
VEON
VEON
$3.93B
| $18.6K | ﹤0.01% |
+720
| New | +$18K |
|
|
CHCT
1391
Community Healthcare Trust
CHCT
$433M
| $18.5K | ﹤0.01% |
798
-10,225
| -93% | -$249K |
|
1392
UroGen Pharma
URGN
$2.34B
| $18.3K | ﹤0.01% |
+1,079
| New | +$15.3K |
|
1393
Wave Life Sciences
WVE
$1.02B
| $18.2K | ﹤0.01% |
+3,656
| New | +$20.9K |
|
1394
Phathom Pharmaceuticals
PHAT
$743M
| $18.2K | ﹤0.01% |
1,748
-12,158
| -87% | -$125K |
|
|
INN
1395
Summit Hotel Properties
INN
$656M
| $18K | ﹤0.01% |
3,099
-42,890
| -93% | -$262K |
|
1396
Erasca
ERAS
$6.25B
| $17.9K | ﹤0.01% |
+7,758
| New | +$16.7K |
|
1397
Zymeworks
ZYME
$1.83B
| $17.8K | ﹤0.01% |
+2,111
| New | +$18.8K |
|
1398
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $17.7K | ﹤0.01% |
+424
| New | +$17.8K |
|
|
HPP
1399
Hudson Pacific Properties
HPP
$787M
| $17.6K | ﹤0.01% |
+523
| New | +$19.7K |
|
1400
Arbutus Biopharma
ABUS
$906M
| $17.5K | ﹤0.01% |
+5,634
| New | +$16.9K |
|
Similar funds
BC
Mirae Asset Global Investments's Q2 2024 Portfolio in Review
As of Q2 2024, Mirae Asset Global Investments held 2,693 positions worth $20.1B, down 56% from $46.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments withdrew a net $34.7B in Q2 2024, closing 1,170 positions and reducing 1,071 holdings. Its most notable exit was Vanguard Russell 2000 ETF, an estimated $449M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Mirae Asset Global Investments opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $15.6M.
- Mirae Asset Global Investments's largest Q2 2024 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $15.6M.
- Mirae Asset Global Investments added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $75M increase.
- Mirae Asset Global Investments's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.53B.
- Mirae Asset Global Investments fully exited Vanguard Russell 2000 ETF in Q2 2024, selling an estimated $449M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $20.1B portfolio in Q2 2024.
- Mirae Asset Global Investments opened 259 new positions and closed 1,170 in Q2 2024.
- Mirae Asset Global Investments's portfolio value fell 56% quarter-over-quarter to $20.1B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.